Stocks · Health care · Biological Products, (No Diagnostic Substances)

RECURSION PHARMACEUTICALS, INC.

RXRX Clue Score60

United States Fiscal year ends December CIK 0001601830 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$522.20K

$397.20K on a plan · $125.00K straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$522.20K

$0.00 against sales at will